DSM Pharmaceuticals Inc. has expanded its service offerings to include formulation development and clinical trial manufacturing for solid dosage form products.

“This expansion of services will have significant value-added benefits to our customers in terms of reducing cost and accelerating time to market as they will be able to avoid the high cost of tech transfers required for commercial launch by conducting development, CTM and commercial manufacturing all at DSM’s Greenville, NC facilities,” said Terry Novak, president and business unit director of DSM Pharmaceuticals, Inc.

Pharmaceutical development services will include: preformulation, analytical development, stability studies, formulation development, NCE formulation development, reformulations for line extensions, controlled and modified release, controlled substances, clinical trial supply – Phase I-III regulatory support.